Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase

EMBO Journal

Volumn 18, Issue 15, 1999, Pages 4280-4291

  Vandel, Laurence ^a   Kouzarides, Tony ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

cdk7; Degradation; E2F 1; Phosphorylation; TFIIH

Indexed keywords

ALANINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

AMINO ACID SUBSTITUTION; ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA-BINDING PROTEINS; DROSOPHILA PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HELA CELLS; HUMANS; HYDROLYSIS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; S PHASE; SEQUENCE HOMOLOGY, AMINO ACID; SERINE; THREONINE; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; TRANSCRIPTION, GENETIC;

EID: 0033517132     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.15.4280     Document Type: Article

References (71)

1. Adamczewski, J.P., Rossignol, M., Tassan J.P., Nigg, E.A., Moncollin, V. and Egly, J.M. (1996) MAT-1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH. EMBO J., 15, 1877-1889.
2. Akoulitchev, S. and Reinberg, D. (1998) The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of Cdk7. Genes Dev., 12, 3541-3550.
3. Amati, B., Alevizopoulos, K. and Vlach, J. (1998) MYC and the cell cycle. Frontiers Biosci., 3, 250-268.
4. Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J. and Kouzarides, T. (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature, 391, 597-601.
5. Mo15, the catalytic subunit of cdk-activating kinase, during Xenopus oogenesis and embryogenesis. Mol. Biol. Cell., 5, 921-932.
6. Campanero, M.R. and Flemington, E.K. (1997) Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl Acad. Sci. USA, 94, 2221-2226.
7. Chellappan, S.P., Hiebert, S., Mudryj, M., Horowitz, J.M. and Nevins, J.R. (1991) The E2F transcription factor is a cellular target for the RB protein. Cell, 65, 1053-1061.
8. Clurman, B.E., Sheaff, R.J., Thress, K., Groudine, M. and Roberts, J.M. (1996) Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev., 10, 1979-1990.
9. Dalton, S. (1992) Cell cycle regulation of the human cdc2 gene. EMBO J., 11. 1797-1804.
10. Diehl, J.A., Zindy, F. and Sherr, C.J. (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev., 11, 957-972.
11. Dynlacht, B.D., Flores, O., Lees, J.A. and Harlow, E. (1994) Differential regulation of E2F trans-activation by cyclin-cdk2 complexes. Genes Dev., 8, 1772-1786.
12. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev., 12, 2245-2262.
13. K1P cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J., 18, 644-653.
14. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J. and Livingston, D.M. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73, 487-497.
15. Fagan, R.K., Flint, K.J. and Jones, N. (1994) Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell, 78, 799-811.
16. Geng, Y., Eaton, E.N., Picon, M., Roberts, J.M., Lundberg, A.S., Gifford, C., Sardet, C. and Weinberg, R.A. (1996) Regulation of cyclin E transcription of E2Fs and retinoblastoma protein. Oncogene, 12, 1173-1180.
17. Gerard, M., Fisher, L., Moncollin, V., Chipoulet, J.M., Chambon, P. and Egly, J.M. (1991) Purification and interaction properties of the human RNA polymerase B (II) general transcription factor BTF2. J. Biol. Chem., 266, 20940-20945.
18. Hagemeier, C., Cook, A. and Kouzarides, T. (1993) The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res., 21, 4998-5004.
19. Hateboer, G., Kerkhoven, R.M., Shvarts, A., Bernards, R. and Beijersbergen, R.L. (1996) Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev., 10, 2960-2970.
20. Helin, K. (1998) Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev., 8, 28-35.
21. Hiebert, S.W., Lipp, M. and Nevins, J.R. (1989) E1A-dependent transactivation of the human MYC promoter is mediated by the E2F factor. Proc. Natl Acad. Sci. USA, 86, 3594-3598.
22. Hiebert, S.W., Blake, M., Azizkhan, J. and Nevins, J.R. (1991) Role of E2F transcription factor in E1A-mediated transactivation of cellular genes. J. Virol., 65, 3547-3552.
23. Hiebert, S.W., Chellapan, S.P., Horowitz, J.M. and Nevins, J.R. (1992) The interaction of RB with E2F-coincides with an inhibition of the transcriptional activity of E2F. Genes Dev., 6, 177-185.
24. 1 exit. Genes Dev., 10, 851-861.
25. Hofmann, F., Martelli, F., Livingston, D.M. and Wang, Z. (1996) The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev., 10, 2949-2959.
26. Hsiao, K., McMahon, S.L. and Farnham, P.J. (1994) Multiple DNA elements are required for the growth regulation of the mouse E2F-1 promoter. Genes Dev., 8, 1526-1537.
27. Johnson, D.G., Schwarz, J.K., Cress, W.D. and Nevins, J.R. (1993) Expression of transcription factor E2F-1 induces quiescent cells to enter S phase. Nature, 365, 349-352.
28. Johnson, D.G., Ohtani, K. and Nevins, J.R. (1994) Autoregulatory control of E2F-1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev., 8, 1514-1525.
29. Kaelin, W.G.J. et al. (1992) Expression cloning of a cDNA encoding a retinoblastoma binding protein with E2F-like properties. Cell, 70, 351-354.
30. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E. and Sherr, C.J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRB) and pRB phosphorylation by the cyclin D-dependent kinase cdk4. Genes Dev., 7, 331-342.
31. Kitagawa, M., Higashi, H., Suzuki-Takahashi, I., Segawa, K., Hanks, S.K., Taya, Y., Nishimura, S. and Okuyama, A. (1995) Phosphorylation of E2F-1 by cyclin A/cdk2. Oncogene, 10, 229-236.
32. 1-S transition: the SCF connection. Curr. Opin. Genet. Dev., 8, 36-42.
33. Krek, W., Ewen, M.E., Shirodkar, S., Arany, Z., Kaelin, W.G.J. and Livingston, D.M. (1994) Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell, 78, 161-172.
34. Krude, T., Jackman, M., Pines, J. and Laskey, R.A. (1997) Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell, 88, 109-119.
35. Lam, E.W. and Watson, R.J. (1993) An E2F binding site mediates cell cycle regulated repression of mouse B-myb transcription. EMBO J., 12, 2705-2713.
36. Lundberg, A.S. and Weinberg, R.A. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification of at least two distinct cyclin-cdk complexes. Mol. Cell. Biol., 18, 753-761.
37. Luo, R.X., Postigo, A.A. and Dean, D.C. (1998) RB interacts with histone deacetylase to repress transcription. Cell, 92, 463-473.
38. Lutterbach, B. and Hann, S.R. (1994) Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol. Cell. Biol., 14, 5510-5522.
39. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J.P., Troelen, F., Trouche, D. and Harel-Bellan, A. (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature, 391, 601-605.
40. Mäkela, T.P., Parvin, J.D., Kim, J., Huber, L.J., Sharp, P.A. and Weinberg, R.A. (1995) A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. Proc. Natl Acad. Sci. USA, 92, 5174-5178.
41. KIP1 levels by cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J., 18, 654-663.
42. Martin, K., Trouche, D., Hagemeier, C., Sørensen, T.S., La Thangue, N.B. and Kouzarides, T. (1995) Stimulation of E2F-1/DP-1 transcriptional activity by MDM2 oncoprotein. Nature, 375, 691-694.
43. Matsuoka, M., Kato, J.Y., Fisher, R.P., Morgan, D.O. and Sherr, C.S. (1994) Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol., 14, 7265-7275.
44. Meijer, L. (1995) Chemical inhibitors of cyclin-dependent kinases. Prog. Cell Cycle Res., 1, 351-363.
45. Mittnacht, S. (1998) Control of pRB phosphorylation. Curr. Opin. Genet. Dev., 8, 21-27.
46. Mudryj, M.S., Hiebert, S.W. and Nevins, J.R. (1990) A role for the adenovirus inducible E2F transcription factor in a proliferation-dependent signal transduction pathway. EMBO J., 9, 2179-2184.
47. 1 cyclin-dependent kinase inhibitor, is dependent on cdk2 activity and the proteasome. Mol. Cell. Biol., 19, 1190-1201.
48. 0'Connor, D.J., Lam, E.W., Griffin, S., Zhong, S., Leighton, L.C., Burbidge, S.A. and Lu, X. (1995) Physical and functional interaction between DP-1 and p53 and cell cycle co-operating transcription factors, E2F-1 and DP-1. EMBO J., 14, 6184-6192.
49. Ohtani, K., DeGregori, J. and Nevins, J.R. (1995) Regulation of the cyclin E gene by transcription factor E2F. Proc. Natl Acad. Sci. USA, 92, 12146-12150.
50. Patton, E.E., Willems, A.R. and Tyers, M. (1998) Combinatorial control in ubiquitin-dependent proteolysis: don't skp the F-box hypothesis. Trends Genet., 14, 236-243.
51. Pearson, A. and Greenblatt, J. (1997) Modular organization of the E2F-1 activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene, 15, 2643-2658.
52. Peeper, D.S., Keblusek, P., Helin, K., Toebes, M., van der Eb, A.J. and Zantema, A. (1995) Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro. Oncogene, 10, 39-48.
53. Peterson, S.R., Dvir, A., Anderson, C.W. and Dynan, W.S. (1992) DNA binding provides a signal for phosphorylation of the RNA polymerase II hexapeptide repeats. Genes Dev., 6, 426-438.
54. cdc2. EMBO J., 12, 3123-3132.
55. Pulverer, B.J., Fisher, C., Vousden, K., Littlewood, T., Evan, G. and Woodgett, J.R. (1994) Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene, 9, 59-70.
56. Rao, P.N. and Johnson, R.T. (1970) Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis. Nature, 225, 159-164.
57. Rossignol, M., Kolb-Cheynel, I. and Egly, J.M. (1997) Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J., 16, 1628-1637.
58. Roy, R., Adamczewski, J.P., Seroz, T., Vermuelen, W., Tassan, J.P., Schaeffer, L., Nigg, E.A., Hoeijmakers, J.H.J. and Egly, J.M. (1994) The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell, 79, 1093-1101.
59. Salghetti, S.E., Kim, S.Y. and Tansey, W.P. (1999) Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J., 18, 717-726.
60. Schulze, A., Zerfass, K., Spitkovsky, D., Middendorp, S., Berges, J., Helin, K., Jansen-Durr, P. and Henglein, B. (1995) Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl Acad. Sci. USA, 92, 11264-11268.
61. Serizawa, H., Conaway, J.W. and Conaway, R.C. (1993) Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription. Nature, 363, 371-374.
62. Shan, B., Zhu, X., Chen, P.L., Durfee, T., Yang, Y., Sharp, D. and Lee, W.-H. (1992) Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol., 12, 5620-5631.
63. Shiekhattar, R., Mermelstein, F., Fisher, R.P., Drapkin, R., Dynlacht, B., Wessling, H.C., Morgan, D.O. and Reinberg, D. (1995) Cdk-activating kinase (CAK) complex is a component of human transcription factor IIH. Nature, 374, 283-287.
64. Slansky, J.E., Li, Y., Kaelin, W.G.J. and Farnham, P.J. (1993) A protein synthesis-dependent increase in E2F-1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol., 13, 1610-1618.
65. Svejstrup, J.Q., Vichi, P. and Egly, J.M. (1996) The multiple roles of transcription/repair factor TFIIH. Trends Biochem. Sci., 20, 402-405.
66. Tassan, J.P., Schultz, S.J., Bartek, J. and Nigg, E.A. (1994) Cell cycle analysis of the activity, subcellular localization and subunit composition of human CAK (Cdk-activating kinase). J. Cell Biol., 127, 467-478.
67. Trouche, D. and Kouzarides, T. (1996) E2F-1 and E1A 12S have a homologous activation domain regulated by RB and CBP. Proc. Natl Acad Sci. USA, 93, 1439-1442.
68. Won, K.A. and Reed, S.I. (1996) Activation of cyclin E/cdk2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J., 15, 4182-4193.
69. Xu, M.K., Sheppard, K.A., Peng, C.Y., Yee, A.S. and Piwnica-Worms, H. (1994) Cyclin A/cdk2 binds directly to E2F-1 and inhibits the DNA binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol., 14, 8420-8431.
70. Yankulov, K.Y. and Bentley, D.L. (1997) Regulation of cdk7 substrate specificity by MAT-1 and TFIIH. EMBO J., 16, 1638-1646.
71. Yankulov, K.Y., Yamashita, K., Roy, R., Egly, J.-M. and Bentley, D.L. (1995) The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated kinase. J. Biol. Chem., 270, 23922-23925.